Table of Contents:
- Management of high-risk non-muscle invasive bladder cancer: adjuvant intravesical BCG therapy and alternatives
- Tumour-derived organoids and future clinical applications
- Practical guidelines in axillary management after neo-adjuvant chemotherapy in breast cancer patients
- Reactivations of prior infections in cancer patients treated with immunosuppressive/immunomodulatory treatments
- Intensified neoadjuvant chemotherapy with SBRT for a borderline resectable pancreatic cancer: A plea for prospective evaluation
- Optimising target volume definition and treatment accuracy in oesophageal cancer
- New oncology reimbursements in Belgium
